Production and effects of interleukin-6 and other cytokines in patients with non-Hodgkin's lymphoma

Leukemia and Lymphoma

Volumn 29, Issue 1-2, 1998, Pages 71-79

  Kato, Hirokazu ^a   Kinoshita, Tomohiro ^a   Suzuki, Sadao ^c   Nagasaka, Tetsuro ^b   Hatano, Sonoko ^b   Murate, Takashi ^b   Saito, Hidehiko ^b   Hotta, Tomomitsu ^d  

^a Nishio Municipal Hospital   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d TOKAI UNIVERSITY   (Japan)

Author keywords

B symptoms; Cytokines; IL 6; NHL

Indexed keywords

ACUTE PHASE PROTEIN; CYTOKINE; IMMUNOGLOBULIN; INTERLEUKIN 6;

B CELL LYMPHOMA; BLOOD LEVEL; CYTOKINE PRODUCTION; HUMAN; IMMUNOGLOBULIN PRODUCTION; LIVER CELL; MYELOMA CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW;

EID: 0031862153     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809058383     Document Type: Review

References (46)

1. Foon, K. A. and Tood, R. F. III (1986). Immunologic classification of leukemia and lymphoma. Blood, 68, 1-31.
2. Magrath, I. (1990). Lymphocyte Ontogeny: A conceptual basis for understanding neoplasia of the immune system. In: The Non-Hodgkin's Lymphoma, I. Magrath (ed). pp. 29-48. (Williams & Wilkins, Baltimore.)
3. Arai, K., Lee, F., Miyajima, A., Miyatake, S., Arai, N. and Yokota, T. (1990). Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem., 59, 783-836.
4. Whicher, J. T. and Evans, S. W. (1990). Cytokines in disease. Clin. Chem., 36, 1269-1281.
5. Hansson, M. (1990). Growth and differentiation factors for B-and T-cells. Leuk. Res., 14, 705-710.
6. Bendtzen, K. (1988). Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation, and immunity. Immunol. Lett., 19, 183-192.
7. Akira, S., Hirano, T., Taga, T. and Kishimoto, T. (1990). Biology of multifunctional Cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J., 4, 2860-2867.
8. Dinarello, C. A. (1989). Interleukin-1 and its biologically related cytokines. Adv. Immunol., 44, 153-206.
9. Hsu, S-M., James, W. W. Jr., Hsu, P-L. and Aubrey, J. H. Jr. (1993). Cytokines in malignant lymphomas: review and prospective evaluation. Hum. Pathol., 24, 1040-1057.
10. Merz, H., Houssiau, F. A., Orscheschek, K., Renauld, J. C., Fliedner, A., Herin, M., Noel, H., Kadin, M., Mueller-Hermelink, H. K., Van Snick, J. and Feller, A. C. (1991). Interleukin-9 expression in human malignant lymphoma: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood, 78, 1311-1317.
11. Hsu, P-L. and Hsu, S-M. (1989). Production of tumor necrosis factor-α and lymphotoxin (TNF-γ) by cells of Hodgkin's neoplastic cell lines HDLM-1 and KM-H2. Am. J. Pathol., 135, 735-745.
12. Hsu, S-M., Xie, S-S. and Waldron, J. W. Jr. (1992). Functional heterogeneity and pathologic significance of interleukin-6 in B-cell lymphomas. Am. J. Pathol., 141, 915-923.
13. Kishimoto, T. (1989). The biology of interleukin-6. Blood, 74, 1-10.
14. Muraguchi, A., Kishimoto, T., Miki, Y., Kuritani, T., Kaieda, T., Yoshizaki, K. and Yamamura, Y. (1981). T-cell-replacing factor (TRF)-induced IgG secretion in human B blastoid cell line and demonstration of acceptors for TRF. J. Immunol., 127, 412-416.
15. Hirano, T., Taga, T., Nakano, N., Yasukawa, K., Kashiwamura, S., Shimizu, K., Nakajima, K., Pyun, K-H. and Kishimoto, T. (1985). Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSF-2). Proc. Natl. Acad. Sci. USA., 82, 5490-5494.
16. Scala, G., Quinto, I., Ruocco, M. R., Arcucci, A., Mallardo, M., Caretto, P., Forni, G. and Venuta, S. (1990). Expression of an exogenous interleukin-6 gene in human Epstein Barr virus B-cells confers growth advantage and tumorigenicity. J. Exp. Med., 172, 61-68.
17. Woodroofe, C., Muller, W. and Ruther, U. (1992). Long-term consequences of interleukin-6 overexpression in transgenic mice. DNA Cell Biol., 11, 587-592.
18. Yee, C-Y., Biondi, A., Wang, X-H., Iscove, N. N., de-Sousa, J., Aarden, L. A., Wong, G-G., Clark, S. C., Messuer, H. A. and Mindeu, M. D. (1989). A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood, 74, 798-804.
19. Takeshita, M., Sumiyoshi, Y., Masuda, Y., Ohshima, K., Yoshida, T., Kikuchi, M. and Muller, H. (1993). Cytokine (interleukin-1α, interleukin-1β, tumor necrosis factor α, and interleukin-6)-possessing cells in lymph nodes of malignant lymphoma. Pathol. Res. Pract., 189, 18-25.
20. Freeman, G. J., Freedman, A. S., Rabinowe, S. N., Segil, J. M., Horowitz, J., Rosen, K., Whitman, J. F. and Nadler, L. M. (1989). Interleukin 6 gene expression in normal and neoplastic B-cells. J. Clin. Invest., 83, 1512-1518.
21. Emilie, D., Coumbaras, J., Raphael, M., Devergne, O., Delecluse, H. J., Gisselbrecht, C., Michiels, J. F., Van Damme, J., Taga, T., Kishimoto, T., Crevon, M. C. and Galanaud, P. (1992). Interleukin-6 production in high-grade B-lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. Blood, 80, 498-504.
22. Pluda, J. M., Venzon, D. J., Tosato, G., Lietzau, J., Wyvill, K., Nelson, D. L., Jaffe, E. S., Karp, J. E., Broder, S. and Yarchoan, R. (1993). Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J. Clin. Oncol., 11, 1099-1107.
23. Tosato, G., Jones, K., Breinig, M. K., McWilliams, H. P. and McKnight, J. L. (1993). Interleukin-6 production in posttransplant lymphoproliferative disease. J. Clin. Invest., 91, 2806-2814.
24. Kurzrock, R., Redman, J., Cabanillas, F., Jones, D., Rothberg, J. and Talpaz, M. (1993). Serum interleukin-6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and B symptoms. Cancer Res., 53, 2118-2122.
25. Seymour, J. F., Talpaz, M., Cabanillas, F., Wetzler, M. and Kurzrock, R. (1995). Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma. J. Clin. Oncol., 13, 575-582.
26. Kato, H., Kinoshita, T., Suzuki, S., Nagasaka, T., Murate, T., Saito, H. and Hotta, T. (1996). Elevated serum interleukin-6 (IL-6) is derived from neoplastic lymphoid cells in patients with B-cell non-Hodgkin's lymphoma: correlation with extent of IL-6 expression and serum concentration. Br. J. Haematol., 92, 1014-1021.
27. Emilie, D., Wijdenes, J., Gisselbrecht, C., Jarrousse, B., Billaud, E., Blay, J. Y., Gabarre, J., Gaillard, J. P., Brochier, J., Raphael, M., Boue, F. and Galanaud, P. (1994). Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: Effect of lymphoma growth and on B-clinical symptoms. Blood, 84, 2472-2479.
28. Gauldie, J., Richards, C., Harnish, D., Landsorp, P. and Baumann, H. (1987). Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA., 84, 7251-7255.
29. Klein, B., Wijdenes, J., Zhang, X-G., Jourdan, M., Boiron, J. M., Brochier, J., Liautard, J., Merlin, M., Clement, C., Morel-Fournier, B., Lu, Z-Y., Mannoni, P., Sany, J., Bataille, R. (1991). Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood, 78, 1198-1204.
30. Kuby, J. (1994). Role of cytokines in the inflammatory response. In: Immunology (second edition). J. Kuby (ed.), pp. 313-315. (W. H. Freeman and Company, New York, NY.)
31. Hollen, C. W., Henthorn, J., Koziol, J. A. and Burstein, S. A. (1991). Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br. J. Haematol., 79, 286-290.
32. Blay, J-V., Favrot, M., Rossi, J-F. and Wijdenes, J. (1993). Role of interleukin-6 in paraneoplastic thrombocytosis. [letter] Blood, 82, 2261-2262.
33. Mule, J. J., Marcus, S. G., Yang, J. C., Weber, J. S. and Rosenberg, S. A. (1992). Clinical application of IL-6 in cancer therapy. Res. Immunol., 143, 777-779.
34. Weber, I., Yang, J. C., Topalian, S. L., Parkinson, D. R., Schwartzentruber, D. S., Ettinghausen, S. E., Gunn, H., Mixon, A., Kim, H., Cole, D., Levin, R. and Rosenberg, S. A. (1993). Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J. Clin. Oncol., 11, 499-506.
35. Rennick, D., Jackson, J., Yang, G., Wideman, J., Lee, F. and Hudak, S. (1989). Interleukin-6 interacts with interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakariocytic, erythroid, myeloid, and multipotential progenitor cells. Blood, 73, 1828-1835.
36. Koike, K., Nakahata, T., Takagi, M., Kobayashi, T., Ishiguro, A., Tsuji, K., Naganuma, K., Okano, A., Akiyama, Y. and Akabane, T. (1988). Synergism of BSF-2/interleukin-6 and interleukin-3 on development of multipotential hemopoietic progenitors in serum free culture. J. Exp. Med., 168, 879-890.
37. Gardner, J. D., Liechty, K. W. and Christensen, R. D. (1989). Effects of interleukin-6 on fetal hematopoietic progenitors. Blood, 75, 2150-2155.
38. Caracciolo, D., Clark, S. C. and Rovera, G. (1989). Human interleukin-6 supports granulocytic differentiation of hematopoietic progenitor cells and acts synergistically with GM-CSF. Blood, 73, 666-670.
39. Janzen, J. H., Kluin-Nelemans, J. C., Van Damme, J., Wientjens, G. J. H. M., Willemze, R. and Fibbe, W. E. (1992). Interleukin 6 is a permissive factor for monocytic colony formation by human hematopoietic progenitor cells. J. Exp. Med., 175, 1151-1154.
40. Klein, B., Zhang, X-G., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M. and Bataille, R. (1989). Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood, 73, 517-526.
41. Muraguchi, A., Hirano, T., Tang, B., Matsuda, T., Horii, Y., Nakajima, K. and Kishimoto, T. (1988). The essential role of B-cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B-cells. J. Exp. Med., 167, 332-344.
42. Paul, W. E. and Ohara, J. (1987). B-cell stimulatory factor-1/interleukin-4. Annu. Rev. Immunol., 5, 429-459.
43. Harriman, G. R., Kunimoto, D. Y., Elliott, J. F., Paetkau, V. and Strober, W. (1988). The role of IL-5 in IgA B-cell differentiation. J. Immunol., 140, 3033-3039.
44. Ishizaka, A., Sakiyama, Y. and Nakanishi, M. (1990). The inductive effect interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes. Clin. Exp. Immunol., 79, 392-396.
45. Pelliniemi, T. T., Irjala, K., Pulkki, K., Rajamäki, A., Tienhaara, A., Laakso, M. and Lahtinen, R. (1995). Immunoreactive interleukin-6 and acute phase protein as prognostic factors in multiple myeloma. Blood, 85, 765-771.
46. Seymour, J. F., Talpaz, M., Cabanillas, F., Wetzler, M. and Kurzrock, R. (1995). Serum Interleukin-6 levels correlate with prognosis in diffuse large cell lymphoma. J. Clin. Oncol., 13, 575-582.